We are live on
!
Find out more
AG
Aperio Group Portfolio holdings
AUM
$33.8B
1-Year Est. Return
31.46%
This Fund
S&P 500
This Quarter
Est. Return
+3.3%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
–
AUM
$12.8B
AUM Growth
+$1.1B
(+9.4%)
Cap. Flow
+$840M
Cap. Flow
% of AUM
6.56%
Top 10 Holdings %
Top 10 Hldgs %
12.13%
Holding
2,105
New
79
Increased
1,204
Reduced
715
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$16.2M |
| 2 |
Johnson & Johnson
JNJ
|
+$15.2M |
| 3 |
AT&T
T
|
+$14.3M |
| 4 |
ExxonMobil
XOM
|
+$14.1M |
| 5 |
IBM
IBM
|
+$13.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$21.6M |
| 2 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$12.3M |
| 3 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$11.1M |
| 4 |
SNDK
SANDISK CORP
SNDK
|
+$7.05M |
| 5 |
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
|
+$6.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.06% |
| 2 | Healthcare | 14.21% |
| 3 | Technology | 14.12% |
| 4 | Consumer Staples | 9.51% |
| 5 | Industrials | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Pinnacle Financial Partners Inc
PNFP
$15.8B
| $259K | ﹤0.01% |
5,309
+287
| +6% | +$14.1K |
|
1727
Rambus
RMBS
$9.72B
| $259K | ﹤0.01% |
21,430
-1,191
| -5% | -$14.5K |
|
|
VIVO
1728
DELISTED
Meridian Bioscience Inc
VIVO
| $258K | ﹤0.01% |
13,207
-2,735
| -17% | -$53.6K |
|
1729
Guidewire Software
GWRE
$12.8B
| $256K | ﹤0.01% |
4,141
+319
| +8% | +$18.4K |
|
1730
John Wiley & Sons Class A
WLY
$2.66B
| $256K | ﹤0.01% |
4,913
+208
| +4% | +$10.5K |
|
1731
CONMED
CNMD
$1.41B
| $255K | ﹤0.01% |
5,337
-737
| -12% | -$31.2K |
|
1732
Hecla Mining
HL
$10B
| $255K | ﹤0.01% |
49,914
+1,646
| +3% | +$6.65K |
|
|
DATA
1733
DELISTED
Tableau Software, Inc.
DATA
| $255K | ﹤0.01% |
5,211
+572
| +12% | +$28.7K |
|
1734
Cato Corp
CATO
$66.5M
| $254K | ﹤0.01% |
6,721
+1,289
| +24% | +$48K |
|
1735
OneMain Financial
OMF
$7.32B
| $254K | ﹤0.01% |
11,142
-9,777
| -47% | -$277K |
|
1736
Coca-Cola Consolidated
COKE
$12.6B
| $253K | ﹤0.01% |
17,140
-980
| -5% | -$14.3K |
|
1737
Iridium Communications
IRDM
$5.05B
| $253K | ﹤0.01% |
28,477
-11,201
| -28% | -$92K |
|
1738
Comscore
SCOR
$112M
| $253K | ﹤0.01% |
529
+92
| +21% | +$55K |
|
|
AFAM
1739
DELISTED
Almost Family Inc
AFAM
| $253K | ﹤0.01% |
+5,926
| New | +$244K |
|
1740
Griffon
GFF
$4.03B
| $252K | ﹤0.01% |
14,954
+655
| +5% | +$10.6K |
|
1741
NBT Bancorp
NBTB
$2.75B
| $251K | ﹤0.01% |
8,777
+98
| +1% | +$2.76K |
|
1742
Bright Horizons
BFAM
$4.1B
| $250K | ﹤0.01% |
3,763
-691
| -16% | -$45K |
|
1743
Clearway Energy Class C
CWEN
$4.94B
| $249K | ﹤0.01% |
+16,000
| New | +$244K |
|
1744
Old National Bancorp
ONB
$10.1B
| $249K | ﹤0.01% |
19,846
-362
| -2% | -$4.58K |
|
1745
Dillards
DDS
$9.41B
| $248K | ﹤0.01% |
4,091
-47
| -1% | -$3.07K |
|
|
AKRX
1746
DELISTED
Akorn Inc
AKRX
| $248K | ﹤0.01% |
8,691
-549
| -6% | -$15.2K |
|
1747
Westlake Corp
WLK
$9.19B
| $247K | ﹤0.01% |
5,750
-513
| -8% | -$23.4K |
|
1748
US Physical Therapy
USPH
$1.22B
| $246K | ﹤0.01% |
4,094
-700
| -15% | -$38.4K |
|
|
SIR
1749
DELISTED
SELECT INCOME REIT
SIR
| $246K | ﹤0.01% |
+21,558
| New | +$229K |
|
|
EDR
1750
DELISTED
Education Realty Trust Inc
EDR
| $246K | ﹤0.01% |
+5,336
| New | +$224K |
|
Similar funds
OU
CTA
GAM
CCI
SWM
LCM
HCMNY
BII
Aperio Group's Q2 2016 Portfolio in Review
As of Q2 2016, Aperio Group held 2,105 positions worth $12.8B, up 9.4% from $11.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Aperio Group deployed $840M of net new capital in Q2 2016, opening 79 new positions and adding to 1,204 existing holdings. Its largest new stake was S&P Global: 119,543 shares worth $12.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Zimmer Biomet, an estimated $6.43M trimmed.
- Aperio Group's largest Q2 2016 buy was S&P Global: 119,543 shares worth $12.8M.
- Aperio Group added most to Novartis in Q2 2016, an estimated $16.2M increase.
- Aperio Group's biggest Q2 2016 reduction was Zimmer Biomet, cutting an estimated $6.43M.
- Aperio Group fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $21.6M.
- Aperio Group's ten largest holdings make up 12% of its $12.8B portfolio in Q2 2016.
- Aperio Group opened 79 new positions and closed 98 in Q2 2016.
- Aperio Group's portfolio value rose 9.4% quarter-over-quarter to $12.8B.
Based on Aperio Group's 13F filing for Q2 2016, filed 12 Aug 2016.